Medical device companies find an ideal home in the UM BioPark

Published on :

In 2003, a group of University of Maryland officials approached then-mayor Martin O’Malley with a development plan for vacant land along West Baltimore Street, adjacent to University of Maryland, Baltimore’s campus. Today, this ambitious project, the University of Maryland BioPark, boasts nearly three dozen life science companies, ranging from leading global firms to mature companies to early-stage ventures.
In recent years, the BioPark has attracted a cluster of early-stage medical device companies. For these young companies, the BioPark offers something even more important than a corporate headquarters: a location on UMB’s campus and in the heart of Maryland’s biomed ecosystem.
“The real magnet to coming to our research park is the University of Maryland, Baltimore,” said UM BioPark Executive Director Jane Shaab. “As a leading academic medical center, the quality and scope of research going on here is what companies want to access.”

JuneBrain Joins Thriving Medtech Community at the University of Maryland BioPark

Headshot of Samantha Scott, JuneBrain CEO
Published on :

JuneBrain is located in Baltimore and was founded by Dr. Samantha Scott in 2017. The company is a medtech startup that has the potential to improve the lives of the nearly 500 million patients suffering from neurological and retinal diseases. Dr. Scott has developed a prototype for a wearable, telehealth eye-scanning solution that allows providers to identify new disease activity outside of the clinic for patients suffering from diseases like multiple sclerosis (MS) and age-related macular degeneration (AMD), among others. 

Longeviti Welcomes Renowned Neurosurgeon, Leading Cerebral Expert, Dr. David Langer as New Chief Medical Officer

Published on :

Longeviti Neuro Solutions, developer of the first low-profile intracranial devices that meet the functional and reconstructive needs of brain surgery patients, has hired Dr. David Langer as chief medical officer.  With more than 22 years of experience in highly personalized direct patient care and expertise in medical technology, Dr. Langer will develop and drive the clinical strategy to expand use of Longeviti’s innovative solutions for patients undergoing complex brain surgery.

“Make Your Medical Device Pitch for Kids!”Competition Accepting Applications

Published on :

Critical Need For Electrophysiology Devices To Treat Pediatric Heart Patients WASHINGTON – (March 23, 2021) – Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. [….]

‘Best Kept Secret’ MDC Provides Path for Medical Device Innovations

Published on :

In the heart of pharmaceutical and medical innovation lies an undiscovered treasure that provides a pathway for med-tech innovation, the Maryland Development Council (MDC). The council is a MedTech Startup Studio that works with inventors to develop their ideas into working prototypes and marketable products.

Baltimore’s Longeviti Launches ClearFit Covers, Allowing Post-Operative Ultrasound Imaging for Brain Surgery Patients

Published on :

Baltimore’s Longeviti Launches ClearFit Covers, Allowing Post-Operative Ultrasound Imaging for Brain Surgery Patients BALTIMORE–(BUSINESS WIRE)–Longeviti Neuro Solutions, a medtech company developing innovative solutions for complex brain surgery, today announced the [….]

5 Questions with John Newby, CEO, Virginia Bio

Published on :

John Newby is the CEO at Virginia Bio, the statewide non-profit trade association for the life science industry. Approximately 300 companies spanning biopharmaceuticals, medical devices, med tech, diagnostics, digital health, bioinformatics, agriculture, and industrial bio and related fields are based in Virginia, mainly clustered around research universities and medical institutions. Virginia Bio is the sole state affiliate and works closely with key national industry organizations BIO, AdvaMed, MDMA, PhRMA and We Work for Health.